Antibody News and Research

RSS
An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.

Further Reading

Flu vaccine significantly reduces stroke risk

Flu vaccine significantly reduces stroke risk

Sexual activity causes physiological changes in the body that increase women's chances of getting pregnant

Sexual activity causes physiological changes in the body that increase women's chances of getting pregnant

Targeting protein used by tumors to help detect food supplies could restrict cancerous cells' ability to grow

Targeting protein used by tumors to help detect food supplies could restrict cancerous cells' ability to grow

Calcitonin-gene related peptide antibody inhibition shows migraine prevention promise

Calcitonin-gene related peptide antibody inhibition shows migraine prevention promise

Brodalumab therapy achieves 100% reduction in psoriasis symptoms

Brodalumab therapy achieves 100% reduction in psoriasis symptoms

Serologic status and autoimmune cerebellar ataxia type predict treatment response

Serologic status and autoimmune cerebellar ataxia type predict treatment response

Study: Biomarkers in maternal blood may predict risk for adverse outcomes in pregnant women with SLE

Study: Biomarkers in maternal blood may predict risk for adverse outcomes in pregnant women with SLE

Unique molecule can bind HIV-infected cells to killer T cells

Unique molecule can bind HIV-infected cells to killer T cells

New targeted therapy shows promise against small cell lung cancer

New targeted therapy shows promise against small cell lung cancer

Teva presents new Reslizumab data at European Respiratory Society (ERS) International Congress 2015

Teva presents new Reslizumab data at European Respiratory Society (ERS) International Congress 2015

Kolltan announces presentation of data from KTN0158 preclinical study in mast cell tumors at ESMO 2015

Kolltan announces presentation of data from KTN0158 preclinical study in mast cell tumors at ESMO 2015

Atezolizumab may change treatment strategies for refractory lung cancer patients

Atezolizumab may change treatment strategies for refractory lung cancer patients

Amgen gets positive CHMP opinions for Kyprolis (carfilzomib) and BLINCYTO (blinatumomab)

Amgen gets positive CHMP opinions for Kyprolis (carfilzomib) and BLINCYTO (blinatumomab)

Researchers reveal potential new treatment methods for fatal brain disease

Researchers reveal potential new treatment methods for fatal brain disease

City of Hope receives gift to open new Judy and Bernard Briskin Center for Multiple Myeloma Research

City of Hope receives gift to open new Judy and Bernard Briskin Center for Multiple Myeloma Research

UCSF researchers successfully separate human muscle stem cells

UCSF researchers successfully separate human muscle stem cells

New cell type appears to drive life-threatening food allergies

New cell type appears to drive life-threatening food allergies

CTCA at Western begins clinical trial that combines immunotherapy with chemotherapy to target sarcomas

CTCA at Western begins clinical trial that combines immunotherapy with chemotherapy to target sarcomas

Thomas Jefferson University provides routine genomic fingerprinting to cancer patients

Thomas Jefferson University provides routine genomic fingerprinting to cancer patients

Amgen, Xencor partner to develop and commercialize new therapeutics for cancer immunotherapy, inflammation

Amgen, Xencor partner to develop and commercialize new therapeutics for cancer immunotherapy, inflammation

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.